Skip to main content
. Author manuscript; available in PMC: 2022 Sep 21.
Published in final edited form as: Anal Lett. 2022 Mar 2;55(13):2074–2088. doi: 10.1080/00032719.2022.2044348

Table 2.

Method Qualification Data for Total Analytes in Male SD Rat Plasma

Compound Concentration Range (ng/mL) LODa (ng/mL) LOQb (ng/mL) Standard c QCd
Intra-day Accuracy (RE, %)e Intra-day Precision (RSD, %)f Intra-day Accuracy (RE, %)e Intra-day Precision (RSD, %)f
P-BZT 10–1000 1.95 10.1 −14.3 to 5.9 1.4 to 18.0 −5.1 to −1.5 8.8 to 15.1
Octrizole 5–100 1.53 5.0 −7.5 to 11.4 0.8 to 9.1 −45.5 to 2.4 8.6 to 27.8
Drometrizole 1–100 0.14 1.0 −8.8 to 4.6 0.4 to 5.0 −25.2 to −3.6 15.8 to 17.3
tBuPrOcEst-BZT 1–100 0.12 1.0g −7.1 to 4.5 g 0.0 to 7.0 −12.2 to 0.7g, −27.3 to −20.5h 6.7 to 10.2g 2.9 to 6.0h
Bumetrizole 1–100 NA 1.0 −8.1 to 17.8 5.5 to 7.3 −17.0 to 0.5 23.1 to 28.1
DiMeEtPh-BZT 1–100 0.22 1.0 −11.5 to 14.0 2.7 to 17.1 3.0 to 4.4 9.3 to 25.7
ditBuCl-BZT 1–100 0.04 1.0 −3.4 to 3.0 1.0 to 8.2 8.5 to 3.2 5.6 to 10.0
DitPe-BZT 5–500 NA 5.0 −18.2 to 17.2 5.0 to 12.9 8.0 to 12.7 4.2 to 8.4
tBu-BZT 1–100 NA 1.0 −13.2 to 11.9 1.6 to 12.4 2.4 to 4.0 8.4 to 23.9
a

LOD= Limit of Detection; 3×Standard Deviation for 6 lower limit of quantitation (LOQ) replicates

b

LOQ=lower limit if quantitation; is the lowest concentration of the calibration curve

c

Estimated based on plasma calibration standards, n = 2

d

Estimated based on low and high-level Quality Control (QC) samples, n = 4; 20 and 800 ng/mL for P-BZT; 9 and 75 ng/mL for Octrizole, 2 and 50 ng/mL for drometrizole, bumetrizole, DiMeEtPh-BZT, and ditBu-BZT; 10 and 250 ng/mL for DitPe-BZT; and 1.5 and 80 ng/mL for total tBuPrOcEst-BZT (as tBuPrOH-BZT))

e

RE %= percent relative error

f

%RSD = percent relative deviation

g

With respect to tBuPrOH-BZT

h

With respect to tBuPrOcEst-BZT